Savage NM[au] - Search Results

Year	Number of Results
1997	1
2009	1
2010	3
2011	4
2012	4
2013	3
2014	1
2015	2
2016	1
2017	3
2018	4
2019	8
2020	5
2021	13
2022	7
2023	6
2024	1

1

Larsen RL, Savage NM. Larsen RL, et al. Among authors: savage nm. Int J Lab Hematol. 2019 Apr;41(2):153-161. doi: 10.1111/ijlh.12955. Epub 2018 Nov 30. Int J Lab Hematol. 2019. PMID: 30499630 Review.

2

Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitment.

Klement JD, Redd PS, Lu C, Merting AD, Poschel DB, Yang D, Savage NM, Zhou G, Munn DH, Fallon PG, Liu K. Klement JD, et al. Among authors: savage nm. Cancer Cell. 2023 Mar 13;41(3):620-636.e9. doi: 10.1016/j.ccell.2023.02.005. Cancer Cell. 2023. PMID: 36917954 Free PMC article.

3

Engaging Pathology Residents in Scholarly Activities.

Singh G, Bollag R, Kolhe R, McMullen A, Savage NM. Singh G, et al. Among authors: savage nm. J Appl Lab Med. 2021 Mar 1;6(2):567-569. doi: 10.1093/jalm/jfaa094. J Appl Lab Med. 2021. PMID: 33674882 Free article. No abstract available.

4

Inclusion and Diversity in Pathology Residency Training.

Savage NM, Bollag R, Singh G. Savage NM, et al. J Appl Lab Med. 2021 Jan 12;6(1):304-306. doi: 10.1093/jalm/jfaa170. J Appl Lab Med. 2021. PMID: 33156913 Free article. No abstract available.

5

Clinical Utility of Optical Genome Mapping and 523-Gene Next Generation Sequencing Panel for Comprehensive Evaluation of Myeloid Cancers.

Sahajpal NS, Mondal AK, Singh H, Vashisht A, Ananth S, Saul D, Hastie AR, Hilton B, DuPont BR, Savage NM, Kota V, Chaubey A, Cortes JE, Kolhe R. Sahajpal NS, et al. Among authors: savage nm. Cancers (Basel). 2023 Jun 16;15(12):3214. doi: 10.3390/cancers15123214. Cancers (Basel). 2023. PMID: 37370824 Free PMC article.

6

Duty Hours Tracking - Is There an App for That?

Jorgensen A, Savage NM, Sun X, Domson G. Jorgensen A, et al. Among authors: savage nm. J Med Educ Curric Dev. 2022 Apr 28;9:23821205221096350. doi: 10.1177/23821205221096350. eCollection 2022 Jan-Dec. J Med Educ Curric Dev. 2022. PMID: 35509685 Free PMC article.

7

Satter KB, Tran PMH, Tran LKH, Ramsey Z, Pinkerton K, Bai S, Savage NM, Kavuri S, Terris MK, She JX, Purohit S. Satter KB, et al. Among authors: savage nm. Cells. 2022 Jan 15;11(2):287. doi: 10.3390/cells11020287. Cells. 2022. PMID: 35053403 Free PMC article.

8

Tumefactive fibroinflammatory lesion successfully treated with Rituximab.

Bishop JL, Bryan LJ, Savage NM, Byrd JK. Bishop JL, et al. Among authors: savage nm. Intractable Rare Dis Res. 2019 May;8(2):138-141. doi: 10.5582/irdr.2019.01061. Intractable Rare Dis Res. 2019. PMID: 31218165 Free PMC article.

9

Light Chain-Predominant Multiple Myeloma Subgroup: Impaired Renal Function Correlates with Decreased Survival.

Singh G, Savage NM, Jillella AP, Bollag RJ. Singh G, et al. Among authors: savage nm. Lab Med. 2022 Mar 7;53(2):145-148. doi: 10.1093/labmed/lmab054. Lab Med. 2022. PMID: 34388245

10

Pathology Job Search and Interview: Perspectives on the United States Experience.

Singh G, Savage NM, Bollag RJ, Booker D. Singh G, et al. Among authors: savage nm. Arch Pathol Lab Med. 2023 Nov 1;147(11):1340-1343. doi: 10.5858/arpa.2022-0247-EP. Arch Pathol Lab Med. 2023. PMID: 36602893 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

58 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year